Agios Pharmaceuticals Competitors and Similar CompaniesClear all
Agios Pharmaceuticals's competitors and similar companies include Forbius, Courier Therapeutics, Olema Oncology and Repare Therapeutics.
 Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. |  Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. |  Courier Therapeutics Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  Repare Therapeutics Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells. | |
Founding Date | Founding Date 2008 | Founding Date 2011 | Founding Date 2015 | Founding Date 2007 | Founding Date 2016 |
Type | Type Public | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Austin, US HQ Montréal, CA | Locations Houston, US HQ Houston, US | Locations San Francisco, US HQ San Francisco, US | Locations Montréal, CA HQ Cambridge, US |
Employees | Employees 53611% increase | Employees 811% decrease | Employees 1 | Employees 9630% increase | Employees 129 |
Valuation ($) | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 679.2 m | Valuation ($) 152.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $54m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $53.5m (FY, 2024) |
Cost of goods | Cost of goods $6.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $47.7m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $53.5m (FY, 2024) |
Net income | Net income ($412.8m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($162.5m) (FY, 2025) | Net income ($84.7m) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 145.1m | Total funding raised $ 150.5m |
For sources of this data, please see the company profile
View Company Profiles
Forbius
HQ
Austin, US
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
View companyCourier Therapeutics
HQ
Houston, US
Employees
1
Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform.
View companyOlema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyRepare Therapeutics
HQ
Montréal, CA
Employees
129
Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.
View company